series-a
Stage
2
Investors
About
Surrozen is a biotechnology company developing regenerative therapeutics by engineering surrogate Wnt agonists to modulate Wnt signaling for tissue repair and regeneration.
Explore Surrozen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.